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BithiopheneReal-time, label-free monitoring offers a wide range of applications to the biotech ﬁeld. We developed an
integrated bio-sensing platform which adapts a circular polarization interferometry conﬁguration and a phase
modulated ellipsometer to improve the performance of biomolecular measurements. An bithiophene-based
conductive linker-5′-(mercapto)-[2, 2′-bithiophene]-5-carboxylic acid was developed for detecting antibody–
antigen interactions. In this study, the biomarker interferon-gamma (IFN-γ), one of the most important indica-
tors of tuberculosis, was chosen to test and verify the sensitivity of our measurement system. Our experimental
results showed that an increase in the concentration of the IFN-γ (64 pM to 1 μM)was usually accompanied by a
phase increase. This result is good evidence that our biosensing system can be useful for analyzing biomolecular
interactions.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
With the development of optical and electrochemistry-based bio-
metrology techniques, biological determinationmethods have progres-
sively improved. In recent years, miniaturized devices have advanced
quickly to meet the trend towards point-of-care devices. Obtaining bio-
molecular interactions that are label-free and in real-time is highly
sought after.
Optical metrology possesses advantages such as non-invasive prob-
ing and label-free detection in biomolecular interaction measure-
ments. Both surface plasmon resonance (SPR) and ellipsometry
systems have been previously studied in detail to analyze surfaces
with an attempt to measure the phase shift of reﬂected light beams
for wide measurement ranges. As biomolecular detection typically
starts out with an assembly of a thin ﬁlm on a ﬂat substrate, it is partic-
ularly suitable for biomolecular ellipsometry measurements. A typical
ellipsometer adopts either a rotating-polarizer or a rotating-analyzer
conﬁguration to obtain the ellipsometric parameters which generally
takes time to obtain and cannot be measured in real-time. Chao and
Han installed an ellipsometer equipped with a photoelastic modulator
to measure the Ψ and Δ ellipsometric parameters [1]. Although the
measurement was in real-time, it still required time for the modulationics, National Taiwan University,
6 5654.
ghts reserved.of the phase retardation due to the control of the photoelasticmodulator.
The works published in 2009 by Han et al. [2] detail an ellipsometer
conﬁguration with a polarizer azimuth angle set at 45° while recording
the sampling beam intensity respectivelywhen the analyzerwas rotated
to 0°, 60°, and 120° azimuth angles respectively. The parameters Δ and
Ψ were calculated by using simple equations in the conﬁguration. We
chose three speciﬁc rotating angles of the analyzer (e.g. splitting
the beam into three and then analyzed them using the three rotated
angle analyzers) so that the parameters Δ and Ψ could be calculated
easily. Han et al. [3] further demonstrated in 2011 that obtaining an
ellipsometric parameterΔ in real-time can provide enough information
to analyze the sample variation in situ. The physical meaning of Δ is the
phase difference between the p-polarized and s-polarized incident
beams. It is similar to the phase difference acquired by a common
path phase-shift interferometry technique. The sensitivity enhance-
ment can be attributed to a physical transduction mechanism and to
the system conﬁguration [4]. Conceptually, the common-path conﬁgu-
ration provides a reference beam denoted by s-polarization for retriev-
ing the exact phase of p-polarized light andwhich enhances the relative
phase difference detection precision [5,6]. For point-wise measurements,
phase-interrogation has advantages such as optimal sensitivity, long-
term stability, and high resolution. All of thismakes it suitable formeasur-
ing real-time changes in label-free molecular binding processes [7].
Interferon-gamma (IFN-γ) is a type of endogenously cytokine
that is secreted in human peripheral blood lymphocytes [8]. Typically,
this biomarker can measure whether a person is at risk for tuberculosis
and to indicate the existence of an inﬂammation [9–11]. SPR technology
and electrochemical immunosensors have been used to monitor the
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antibodies or IFN-γ binding reactions [12–15]. In recent years, RNA and
DNAaptamers have been used to detect IFN-γ using SPR, electrochemical
impedance spectroscopy, and quartz crystal microbalance [16–19]. The
results show that the detection limit of IFN-γ is 100 fM with the RNA
aptamer and 1 pM with the DNA aptamer [16].
Previously, we constructed a system to monitor real-time biomolec-
ular interaction using a common-path conﬁguration sensor [20]. It
included a light source, a SPR coupler, a ﬂexible and precise incident
angle varying system, as well as a quadrature interferometer detection
conﬁguration. One conﬁguration of this system is an ellipsometer. No
matter whether it acts as a SPR or as an ellipsometer, the sensitivity of
the system depends on accurately controlling the incidence angle of
the probing light beam [21]. Since an ellipsometric system is an optical
technique that can be used to analyze surfaces, different reactions asso-
ciated with biomolecular recognition leads to changes in ﬁlm thickness.
More speciﬁcally, different molecular bindings can result in different
optical phase constants that can be detected by an ellipsometer
since it can measure the phase of reﬂected light and provide a larger
measurement range. The aim of this work was to demonstrate the
usefulness of a synthesized conductive linker CS20S (5′-(mercapto)-
[2, 2′-bithiophene]-5-carboxylic acid) and to detect the concentration
difference of IFN-γ by measuring the phase change in corresponding
refractive indices. Using the synthesized conductive linker to form the
self-assembled monolayer (SAM) on the gold chip surface, it acts as a
platform to characterize the biochip surfaces by adopting ellipsometry,
SPR signal changes and electrochemical impedance spectroscopy
techniques. The main emphasis of this paper is on the applicability of
integrating this conductive linker into an ellipsometer which we had
previously incorporated into a previous developed system [20]. It is
expected that the structural features of the CS20S-modiﬁed ﬁlm surface
will be suitable for inhomogeneous solid thin ﬁlms with respect to the
transport of electro-active species.
2. Experimental set-up
2.1. Linker and materials
The conductive linker CS20S, 5′-(mercapto)-[2, 2′-bithiophene]-5-
carboxylic acid was synthesized by our team and dissolved in tetrahy-
drofuran (THF). The reaction formula of the CS20S molecular synthesis
is detailed below:
a. n-BuLi (7.5 mmol) was added in drops to a stirred solution of the cor-
responding 2,2′-bithiophene (5.0 mmol) in anhydrous THF (25 mL)
under N2 at −78 °C. Ethyl chloroformate (5.0 mmol) was added
after one hour and the reactionwas left to reach ambient temperature
gradually, and then extractedwith ethyl acetate/H2O. After removal of
the solvent by reducing the pressure, the reaction mixture was puri-
ﬁed using chromatography.
b. Lithium diisopropylamide (6.0 mmol) was added drop by drop to a
stirred solution of the corresponding substrate (5.0 mmol) in anhy-
drous THF (25 mL) under N2 at−78 °C. Sulfur powder (5.0 mmol)
and ethyl chloroformate (5.0 mmol) were added after one hour then
left to reach ambient temperature, after which it was then extracted
with ethyl acetate/H2O. The solvent was removed using pressure,
and the reaction mixture was puriﬁed using chromatography.c. Sodium hydroxide (3.0 mmol) was added to a stirred solution of the
corresponding substrate (5.0 mmol) in anhydrous THF (25 mL)
under N2 at room temperature for six hours. The reaction was
quenched with hydrochloric acid. The crude reaction mixture was
extracted with ethyl acetate/H2O, the solvent removed by pressure
and the reaction mixture puriﬁed by chromatography.
The recombinant human IFN-γ (carrier-free protein), anti-human
IFN-γ Ab (monoclonal mouse IgG2A) and mouse IgG2A isotype control
(monoclonal mouse IgG2A) were obtained from R&D Systems (Minne-
apolis, MN, USA). The phosphate-buffered solution (PBS), EDC (N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride), NHS (N-
hydroxysuccinimide) and Ethanolamine hydrochloric acid (ETA-HCl)
were all obtained from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Assembly of conductive linker on gold chip
A 1 nm Cr layer was deposited between the SF2 (refractive index:
1.64379 at 632.8 nm wavelength, Schott Inc., Duryea, PA, USA) sub-
strate and a 50 nm Au thin ﬁlm served as the intermediate layer for
the bio-chip (Fig. 1(a)). The IFN-γ sensor was fabricated using this
gold-coated bio-chip. The chips were cleaned in a detergent solution,
then thoroughly ultrasonically cleaned with distilled H2O and dried
with nitrogen. The cleaned chip was then immersed in 5 mMCS20S so-
lution for 12 h to modify the chip surface. Finally, the chips were rinsed
with a THF solution, ethanol, and distilled H2O. The SAM derived from
the developed constructive linker on the gold chip surface was charac-
terized by the SPR and ellipsometry signal changes.
2.3. SPR and ellipsometry systems
In our measurement system, a circularly polarized ellipsometer was
integrated with a quadrature interferometer (Fig. 1(b)) [22]. The light
source used was a 635 nmwavelength laser diode module (VHK™ Cir-
cular Beam Visible Laser Module, Edmund Optics Inc.) and driven by a
5 V DC power supply. Two incident light beams (p- and s-polarized)
were adopted as the monochromatic light source propagating along a
common path. The integrated miniaturized system named OBMorph
(also known as Opto-Bio Morphin) adopted four photo-detectors to
perform the differential phase measurement [20,21]. The sensitivity
for the phase detection in the system was previously experimentally
veriﬁed to be 8.2 × 10−6 (1⁄RIU). A FTA (fault tolerance algorithm)
was integrated in the OBMorph System to compensate and to increase
the system measurement reliability. By simulating the reﬂectivity and
reﬂected phase of the SPR response, an estimated change of the p-
polarized light was found to be within the linear region when the
50 nm Au/1 nm Cr was deposited on top of the SF2 substrate refractive
index illuminated by a 635 nmwavelength incident light beam. (Fig. 1).
2.4. Analysis of CS20S assembly and IFN-γ binding
Experimental work was performed using the OBMorph platform
[20,21]. The ﬂow rate was set at 30 μL/min. A PBS buffer (10 mM PBS,
100 mM NaCl, 2 mM KCl, pH 7.4) was injected into the OBMorph to
cleanse the prepared surface. The linker on the chip surfacewas activated
with a 1:1 mixture of 0.4 M EDC and 0.1 M NHS for 10 min. For the
mouse monoclonal anti-human IFN-γ Ab and IgG2A immobilization,
the antibodies were warmed to room temperature, and then dissolved
in a PBS buffer in a 0.5 μM concentration. The antibody solution was
injected and was allowed to interact with the linker for 20 min. 1 M
ETA-HCl blocking solution (pH 8.5) was injected to reduce non-speciﬁc
Fig. 1. (a) Fabrication of an IFN-γ biosensor. (b) Schematic of an OBMorph system.
Fig. 2. Simulation results of SPR p- and s-polarized phase detection obtained from illumi-
nating a 635 nmwavelength light beam onto a SF2 substrate coated with 50 nm Au and
1 nm Cr. (a) Phase difference of p- and s-polarized reﬂected light beam compared to
sample refractive indices at different incident angles. (b) Reﬂected optical phase of p-
and s-polarizations and the phase difference at different incident angles.
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the PBS buffer and then introduced into the OBMorph at various concen-
trations. After eachmeasured IFN-γ concentration, the chip was washed
with the PBS buffer.
3. Results and discussions
Fig. 2 illustrates the simulation results (FilmWizard Software, v.9.0.4).
These simulation results were obtained from illuminating a 635 nm
wavelength light beam onto a SF2 substrate coated with 50 nm Au and
1 nm Cr. A phase difference between the p- and s-polarized reﬂected
light beams was compared to the simulated sample refractive indices at
different incident angles (Fig. 2(a)). The reﬂected optical phases of the
p- and s-polarizations at different incident angles are shown in
Fig. 2(b). Results show an unequal phase-difference dependency on the
p- and s-polarizationwaves at various incident angles. Fig. 3 shows the in-
clined Lissajous curve induced by the incorrect orientation of the quarter-
wavelength plate due to misalignment. A signal processing algorithm
called fault tolerance algorithm (FTA) [21–24] was performed to show
the optimal mapping data with a least-square solution using an iteration
algorithm, P ≡ 2rp2rs2 cos 2Δ = I2 − I4 and Q ≡ 2rp2rs2 sin 2Δ = I1 − I3.
A LabVIEWprogramwas used to adjust the experimental intensity levelsdetected by the photodetectors. We used different concentrations of a
glucose solution to verify the bio-chip platform measurement accuracy.
Fig. 4 shows a nearly linear relationship between the phase mea-
sured by OBMorph and the concentration of the glucose solution. The
obtained coefﬁcient of determination R2 of the trend line was 0.9950.
The refractive indices at different concentrations of the glucose solution
were obtained using a commercially available refractive index meter
(Kyoto Electronics Manufacturing Co., RA-130). Taking the range of
the ellipsometry measurements into account, the incidence angle was
set at 64.1141°.
We evaluated the accuracy of the OBMorph platform, and show
some results of a variation characterized by the measured variances in
concentration and chips. For an analysis of the CS20S assembly and
IFN-γ binding, CS20S molecules were thiolated to ensure the self-
assembly on the gold chips. The assembly of the CS20S molecules,
anti-human IFN-γ Ab and binding of IFN-γ was investigated. Unmodi-
ﬁed chips and non-conjugated antibodies were tested to verify the
attachment of the speciﬁc binding to the antibody. Figs. 5 and 6 show
the rapid binding of the biomolecules onto the gold surface. Once the
antibody was bound onto the chip, subsequent injection of the ETA
and a related sensing layer were used at varying concentrations
(64 pM–1 μM, 5-fold serial dilutions) of human recombinant IFN-γ on
the same chip to show additional phase signal increases. The experi-
mental process was set up with continuous detection at different con-
centrations of IFN-γ injected into the same chip by a single cycle. In
Fig. 5(a), the phase variation in real-time indicates the immediately
Fig. 3. Experimental response of Lissajous curve. (a) Before FTA calibration and (b) After
FTA calibration.
Fig. 4. Experimental results of the effective index and phase difference at various glucose
concentrations.
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antibody which is a non-speciﬁc type blocking with ETA. The IFN-γ
afﬁnity interactions at 0.5 μM and 1 μM concentrations were also
observed after the saturation binding of the analyte. In summary, we
used monoclonal anti-human IFN-γ Ab to recognize recombinant
human IFN-γ (carrier-free protein). In addition, the IFN-γ reagent was
chosen with a carrier-free condition recognized by the anti-human
IFN-γ Ab as a positive control in our system.
From an immunology perspective, we compared the two antibodies,
mouse IgG2A isotype control and anti-human IFN-γ Ab, to check
whether the antibodies caused non-speciﬁc binding of IFN-γ protein
on this platform. Full trace of the analyte isotype control data is
shown in Fig. 5(b). A nonspeciﬁc mouse IgG2A isotype control instead
of the anti-human IFN-γ Ab was dissolved in the PBS with IFN-γ in an
identical experiment. The same concentration of IFN-γ protein was
injected onto the chip with IgG2A immobilization. Initial analysis of
IFN-γ found it was not possible to bind to the IgG2A at a level from
1.6 nM to 40 nM. The data shows that at 1.6 nM, 8 nM and 40 nM neg-
ative fractions, our set-up provided us with a way to obtain 0.5 μM at
10.2516 phase degree (vs. 57.5665° positive), and 1 μM at 12.1351
phase degree (vs. 92.1565° positive). The results indicated that a signal
associated with IFN-γ protein shows up clearly at a high background
signal from high concentrations of nonspeciﬁc mouse IgG2A isotype
control. In other words, isotype control related to non-speciﬁc binding
will not interfere with the true signal of interest. Since the background
signal is associated the immobilization of a high concentration of anti-
bodies, our data set demonstrates that the measurement of IFN-γ
shows an effective selection in the values of positive control. The results
clearly show that our conﬁguration used with the conductive linker
CS20S can detect different concentrations of IFN-γ which conﬁrms our
system sensitivity.
The total phase changes with the concentration variation depended
on the incidence angle setting. The incident angle was near the SPR
angle, and data shows that the total phase change increases under theFig. 5. A real-time measurement of a bithiophene-based biosensor. (a) Phase changes
induced by biomolecular interaction measured in continuous real-time during binding
process of linker activation, antibody immobilization at 0.5 μMand1 μMof IFN-γ obtained
at a steady state. (b) Speciﬁc binding of IFN-γ proteinwith anti-IFN-γAb as a positive con-
trol and non-speciﬁc binding with IgG2A isotype control.
Fig. 6. Experimental results of a phase difference at various concentrations of INF-γ: (a)
Phase change at varying concentrations. (b) Real-time phase change at varying
concentrations.
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nals at different IFN-γ concentrations binding to the antibody layer.
Fig. 6(a) shows that phase increased with increased IFN-γ concentra-
tion in an almost linear relationship. The phase changes were between
79.5696 and 83.6599° whereas a direct steep linear relationship would
have been from 82.175 to 82.9647° and the IFN-γ concentrations from
0.32 nM to 8 nM. There was a small signﬁcant linear relationship
between the phase difference and concentration variation from 8 nM
to 200 nM. In contrast to Fig. 5 which shows between 203.0135 and
295.3298° at 0.5 μM and 1 μM concentrations, the experimental data
in Fig. 6 shows that the phase measuring mode displays a higher sensi-
tivity within the system.
We evaluated the accuracy of OBMorph, and show some of the
results of the variation characterized by themeasured variances of con-
centrations and chips. To assess the linearity of the assay, samples were
spiked with high concentrations of IFN-γ in various microtubes and
diluted with a PBS buffer to produce samples with values within the
dynamic range of the assay.More than seven samples of known concen-
trationswere tested on one chip (Figs. 6(a) and 6(b)) to assess the intra-
assay precision. To assess the intra-assay precision in Fig. 6, we found
that the maximum background noise was a 0.596° phase which cor-
responded to a 0.33% background noise signal before any sample was
added to the chip. After a sample with 40 nM concentration was
added to the chip, the measured phase angle was found to be 21.19°.
The phase angle was measured 100 times at this state and the standard
deviation of the signal measured was 1.284°, which corresponded to a
concentration error of 2.42 nM. More speciﬁcally, the intra-assay error
of our system is around 6%. For an inter-assay error estimation, a
21.27° phase angle change was obtained when a 1000 nM concentra-
tion sample was added. The standard variation of the experimental
phase signal obtained across 3 chips was found to be 3.47°, which
equaled to a 13.21% sample concentration error. That is, the inter-assay
error of our system is around 13.21%. It is clear that the inter-assayprecision is lower than that of the intra-assay. This is not surprising as dif-
ferent chips create additional errors. We traced the additional errors to
the base-plane design between the optical metrology sub-system of the
OBMorph and the biochip. Some additional measures to improve this
design are currently underway. In this study, we present an intra-chip
variability and inter-chip variability. It should be noted that it is impor-
tant to consider the incident angle dependence bywhich the amount of
inter-chip variation is affected. The biomolecular interaction changes
were discriminating at the lower concentrations, as even the incident
angles were not close to the SPR angle and the phase changes were
not obvious. Under optimal conditions, the detection limit in our system
probability was identiﬁed to be better than 64 pM [22]. We found that
the sensitivity of the phase-interrogation SPRwas predominantly inﬂu-
enced by the optimization of the sample incidence angles.
4. Conclusions
Ourdevelopedmetrology platform includes biologicalmeasurement
data based on interrogating angular and phase functions from SPR and
ellipsometry. Our experimental results clearly show that higher sensi-
tivity and higher resolution can be obtained by adopting our developed
bithiophene-based conductive linker. The performance veriﬁcation
results of this system demonstrate the suitability and accuracy of the
selected biomarker in our optical system. The advantages of this label-
free and real-time monitoring system can be used to analyze biological
reactions such as thickness of thin ﬁlm layers. Furthermore, it provides
uswith a good tool tomeasure protein–protein interaction processes in
biosensing applications.
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